Tamoxifen stimulates arachidonic acid release from rat liver cells by an estrogen receptor-independent, non-genomic mechanism

BMC Cancer

Volumn 3, Issue , 2003, Pages

  Levine, Lawrence ^a  

^a BRANDEIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DACTINOMYCIN; ESTROGEN RECEPTOR; FULVESTRANT; TAMOXIFEN; TRITIUM; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PREVENTION; CELL LABELING; CONCENTRATION RESPONSE; CONTROLLED STUDY; INCUBATION TIME; ISOTOPE LABELING; LIVER CELL; MODULATION; NONHUMAN; PRESCRIPTION; RAT; ANIMAL; CULTURE MEDIUM; DOSE RESPONSE; DRUG EFFECT; FEMALE; METABOLISM; SECRETION (PROCESS);

ANIMALS; ARACHIDONIC ACID; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPATOCYTES; RATS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 3042719060     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-3-24     Document Type: Article

References (23)

1. Jordan VC and Morrow M: Tamoxifen, raloxifene, and the prevention of breast cancer. Endocrin Rev 1999, 20:253-278.
2. MacGregor JI and Jordan VC: Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev 1998, 50:151-196.
3. Katzenellenbogen BS and Katzenellenbogen JA: Defining the "S" in SERMs. Science 2002, 295:2380-2381.
4. Gottardis MM and Jordan VC: Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model. Cancer Res 1987, 47:4020-4024.
5. Levine L: Does the release of arachidonic acid from cells play a role in cancer chemoprevention? FASEB Journal 2003, 17:800-802.
6. Brash AR: Arachidonic acid as a bioactive molecule. J Clin Invest 2001, 107:1339-1345.
7. Surette ME, Fonteh AN, Bernatchez C and Chilton FH: Perturbations in the control of cellular arachidonic acid levels block cell growth and induce apoptosis in HL-60 cells. Carcinogenesis 1999, 20:757-763.
8. Chan TA, Morin PJ, Vogelstein B and Kinzler KW: Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci USA 1998, 95:681-686.
9. Levine L: Stimulated release of arachidonic acid from rat liver cells by celecoxib and indomethacin. Prostaglandins Leukot Essen Fatty Acids 2001, 65:31-35.
10. Levine L: Measurement of arachidonic acid metabolites by radioimmunoassay. Manual of Clinical Laboratory Immunology 3rd edition. Edited by: Rose NR, Friedman H, Fahey JL. Washington DC: American Society for Microbiology; 1986:685-691.
11. Levine L: Nuclear receptor agonists stimulate release of arachidonic acid from rat liver cells. Prostaglandins Leukot Essent Fatty Acids 2002, 67:453-459.
12. Wakeling AE: Use of pure antioestrogens to elucidate the mode of action of oestrogens. Biochem Pharmacol 1995, 49:1545-1549.
13. Couldwell WT, Hinton DR, He S, Chen TC, Sebat I, Weiss MH and Law RE: Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines. FEBS Lett 1994, 345:43-46.
14. Dietze EC, Caldwell LE, Grupin SL, Mancini M and Seewaldt VL: Tamoxifen but not 4-hydroxytamoxifen initiate apoptosis in p53(-) normal human mammary epithelial cells by inducing mitochondrial depolarization. J Biol Chem 2000, 276:5384-5394.
15. Obrero M, Yu DV and Shapiro DJ: Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced programmed cell death. J Biol Chem 2002, 277:45695-45703.
16. Levine L: Proteolysis negatively regulates agonist-stimulated arachidonic acid metabolism. Cell Signal 1998, 10:653-659.
17. Croxtall JD, Choudhury Q, White JO and Flower RJ: Tamoxifen inhibits the release of arachidonic acid stimulated by thapsigargin in estrogen receptor-negative A549 cells. Biochim Biophys Acta 1997, 1349:275-284.
18. Zhang W, Couldwell WT, Song H, Takano T, Lin JH and Nedergaard M: Tamoxifen-induced enhancement of calcium signaling in glioma and MCF-7 breast cancer cells. Cancer Res 2000, 60:5395-5400.
19. Mandlekar S, Yu R, Tan TH and Kong AN: Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells. Cancer Res 2000, 60:5995-6000.
20. Peyrade F, Frenay M, Etienne MC, Ruch F, Guillemare C, Francois E, Namer M, Ferrero JM and Milano G: Age-related difference in tamoxifen disposition. Clin Pharmacol Ther 1996, 59:401-410.
21. Whiting KP, Restall CJ and Brain PF: Steroid hormone-induced effects on membrane fluidity and their roles in non-genomic mechanisms. Life Sciences 2000, 67:743-757.
22. Cato ACB, Nestl A and Mink S: Rapid actions of steroid receptors in cellular signaling pathways. Sci STKE 2002. Reg
23. Hammes SR: The further redefining of steroid-mediated signaling. Proc Natl Acad Sci USA 2003, 100:2168-2170.